Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mandelli

Showing results (541-550 of 573) with videos related to

Pageof 58
Sort By:
Indian Journal of Palliative Care|October 7, 2011
Homecare-based Motor Rehabilitation in Musculoskeletal Chronic Graft Versus Host DiseaseA Tendas, C Boschetto, L Baraldi, et al.
Extremophiles : Life Under Extreme Conditions|May 14, 2017
Thermal adaptation strategies of the extremophile bacterium Thermus filiformis based on multi-omics analysisF Mandelli, M B Couger, D A A Paixão, et al.
Leukemia|August 5, 2005
Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia GroupsS Amadori, S Suciu, R Stasi, et al.
Leukemia|May 17, 2003
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)M Oosterveld, S Suciu, G Verhoef, et al.
Leukemia|September 1, 1996
Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoV Liso, P Iacopino, G Avvisati, et al.
Blood|October 6, 2001
Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDST de Witte, S Suciu, G Verhoef, et al.
British Journal of Haematology|November 25, 2000
Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. Gruppo Italiano Malattie Ematologiche Maligne Dell'AdultoM Montillo, A Tedeschi, L Pagano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) studyA Levis, A P Anselmo, A Ambrosetti, et al.
Leukemia|May 24, 2003
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocolsF Mandelli, R Latagliata, G Avvisati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Acute myeloid leukemia in patients previously diagnosed with breast cancer: experience of the GIMEMA groupL Pagano, A Pulsoni, L Mele, et al.
Pageof 58

Showing results (541-550 of 573) with videos related to

Sort By:
Pageof 58
Indian Journal of Palliative Care|October 7, 2011
Homecare-based Motor Rehabilitation in Musculoskeletal Chronic Graft Versus Host DiseaseA Tendas, C Boschetto, L Baraldi, et al.
Extremophiles : Life Under Extreme Conditions|May 14, 2017
Thermal adaptation strategies of the extremophile bacterium Thermus filiformis based on multi-omics analysisF Mandelli, M B Couger, D A A Paixão, et al.
Leukemia|August 5, 2005
Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia GroupsS Amadori, S Suciu, R Stasi, et al.
Leukemia|May 17, 2003
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)M Oosterveld, S Suciu, G Verhoef, et al.
Leukemia|September 1, 1996
Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoV Liso, P Iacopino, G Avvisati, et al.
Blood|October 6, 2001
Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDST de Witte, S Suciu, G Verhoef, et al.
British Journal of Haematology|November 25, 2000
Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. Gruppo Italiano Malattie Ematologiche Maligne Dell'AdultoM Montillo, A Tedeschi, L Pagano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) studyA Levis, A P Anselmo, A Ambrosetti, et al.
Leukemia|May 24, 2003
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocolsF Mandelli, R Latagliata, G Avvisati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Acute myeloid leukemia in patients previously diagnosed with breast cancer: experience of the GIMEMA groupL Pagano, A Pulsoni, L Mele, et al.
Pageof 58